Timothy P Walbert Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Timothy P Walbert is Chairman, President and CEO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Mar 23, 2016, when has been sold 125,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Timothy P Walbert Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 23 2016	BUY Exercise of conversion of derivative security	-	125,000 Added 24.67%	381,618 Ordinary Shares
Jan 02 2016	SELL Payment of exercise price or tax liability	$668,411 $21.67 p/Share	30,845 Reduced 10.73%	256,618 Ordinary Shares
Jan 02 2016	BUY Exercise of conversion of derivative security	-	81,675 Added 22.13%	287,463 Ordinary Shares
Dec 11 2015	BUY Exercise of conversion of derivative security	$10,327 $4.96 p/Share	2,082 Added 1.0%	205,788 Ordinary Shares
Dec 08 2015	SELL Payment of exercise price or tax liability	$324,809 $21.4 p/Share	15,178 Reduced 6.93%	203,706 Ordinary Shares
Dec 08 2015	BUY Exercise of conversion of derivative security	-	33,211 Added 13.17%	218,884 Ordinary Shares
May 01 2015	BUY Exercise of conversion of derivative security	$725,691 $8.38 p/Share	86,598 Added 33.09%	175,125 Ordinary Shares
Jan 02 2015	SELL Payment of exercise price or tax liability	$337,318 $12.8 p/Share	26,353 Reduced 22.94%	88,527 Ordinary Shares
Jan 02 2015	BUY Exercise of conversion of derivative security	-	81,675 Added 41.55%	114,880 Ordinary Shares
Dec 08 2014	SELL Payment of exercise price or tax liability	$182,704 $12.99 p/Share	14,065 Reduced 29.75%	33,205 Ordinary Shares
Dec 08 2014	BUY Exercise of conversion of derivative security	-	33,210 Added 41.26%	47,270 Ordinary Shares
Nov 19 2014	SELL Open market or private sale	$1,807,500 $12.05 p/Share	150,000 Reduced 91.43%	14,060 Ordinary Shares

Also insider at

XCUR

EXICURE, INC. Healthcare

Director

AUPH

Aurinia Pharmaceuticals Inc. Healthcare

Director

IPSC

Century Therapeutics, Inc. Healthcare

Director

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

SGMT

Sagimet Biosciences Inc.

Director

TPW